T-cadherin抑制子宫内膜异位症中子宫内膜间质细胞的侵袭和迁移
本研究检测了T-cadherin在子宫内膜异位症中的表达,并探讨其对子宫内膜间质细胞侵袭和迁移的调控。结果显示,T-cadherin在异位子宫内膜病灶中表达降低,过表达T-cadherin可抑制子宫内膜间质细胞的侵袭和迁移,并伴随HSP27和JNK磷酸化促进及vimentin、MMP2、MMP9表达下降。
要点
- T-cadherin在异位子宫内膜病灶中表达显著降低,而在位内膜与对照内膜无差异。
- 过表达T-cadherin可抑制子宫内膜间质细胞的侵袭和迁移。
- T-cadherin过表达促进HSP27和JNK磷酸化,降低vimentin、MMP2、MMP9表达。
核心结论
- T-cadherin在异位子宫内膜病灶中表达降低,过表达T-cadherin可抑制子宫内膜间质细胞的侵袭和迁移。
研究设计与样本
- 研究纳入40例子宫内膜异位症患者和24例无子宫内膜异位症患者,检测T-cadherin表达,并分离子宫内膜间质细胞研究过表达T-cadherin对侵袭、迁移和信号通路的影响。
主要发现
- 对照患者正常子宫内膜与内异症患者在位子宫内膜中T-cadherin表达无差异,但异位子宫内膜中T-cadherin表达较对照子宫内膜和患者在位子宫内膜显著降低(P < 0.0001,两者均)。
- Western blot分析显示T-cadherin在异位病灶中表达降低,而在正常对照子宫内膜或内异症在位子宫内膜中未见降低。
- Transwell实验表明过表达T-cadherin抑制子宫内膜间质细胞的侵袭和迁移。
- 过表达T-cadherin促进HSP27(S78/S82)和JNK 1/2/3(T183/Y185, T221/Y223)磷酸化,并降低vimentin、MMP2和MMP9表达。
临床怎么用
- 进一步研究T-cadherin在子宫内膜异位症中的作用可能为该复杂疾病提供新的潜在治疗靶点。
局限性
- 对照组为良性妇科疾病患者(如子宫肌瘤、子宫内膜或宫颈息肉),可能存在与T-cadherin表达和信号通路相关的遗传或表观遗传变异。
- 纳入的子宫内膜异位症和对照患者的病例数有限。
- 本研究仅使用了有或无子宫内膜异位症患者的子宫内膜间质细胞,理想情况下还应使用卵巢子宫内膜异位病灶的异位子宫内膜间质细胞来探讨T-cadherin的功能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: What is the expression level of T-cadherin in endometriosis, and does T-cadherin play a role in regulating invasion and migration of endometrial stromal cells? SUMMARY ANSWER: T-cadherin expression was reduced in ectopic endometriotic lesions compared to eutopic endometrium, and T-cadherin overexpression inhibited the invasion and migration of endometrial stromal cells. WHAT IS KNOWN ALREADY: Endometriosis is a disease that involves active cell invasion and migration. T-cadherin can inhibit cell invasion, migration and proliferation in various cancer cells, but its role in endometriosis has not been investigated. STUDY DESIGN, SIZE, DURATION: We explored the expression status of T-cadherin in 40 patients with and 24 without endometriosis. We also isolated endometrial stromal cells to study the invasion, migration and signaling pathway regulation of T-cadherin overexpression. PARTICIPANTS/MATERIALS, SETTING, METHODS: Patients were recruited at the Guangzhou Women and Children's Medical Center to study the expression levels of T-cadherin. The expression of T-cadherin was detected by immunohistochemistry staining and western blot. H-score was used to evaluate the staining intensity of T-cadherin. The correlation between T-cadherin expression levels (H-score) and endometriosis patients' age, stage, lesion size and adhesion was analyzed. Endometrial stromal cells from patients with and without endometriosis were isolated, and cell invasion and migration were detected by transwell assays after T-cadherin overexpression. The expression of vimentin in T-cadherin-overexpressed cells was detected by western blot. After T-cadherin overexpression, the phosphorylation profile of signaling pathway proteins was detected with the Proteome Profiler Human Phospho-Kinase Array Kit. MAIN RESULTS AND THE ROLE OF CHANCE: There was no difference in the expression of T-cadherin in the normal endometrium of control patients and the eutopic endometrium of endometriotic patients, but it was significantly decreased in the ectopic endometrium of endometriotic patients, compared with control endometrium and eutopic endometrium of endometriosis patients (P < 0.0001, for both). Western blot analysis also showed that the expression of T-cadherin was decreased in ectopic endometriotic lesions, but not the normal control endometrium or the endometriotic eutopic endometrium. The results of transwell assays indicated that T-cadherin overexpression inhibited the invasion and migration of endometrial stromal cells. In addition, T-cadherin overexpression promoted the phosphorylation of HSP27 (S78/S82) and JNK 1/2/3 (T183/Y185, T221/Y223) and decreased the expression of vimentin, MMP2 and MMP9 in eutopic endometriosis stromal cells. LARGE-SCALE DATA: N/A. LIMITATIONS, REASONS FOR CAUTION: The control group were patients with benign gynecological conditions (e.g. uterus myoma, endometrial or cervical polyp), which may have genetic or epigenetic variations associated with T-cadherin expression and signaling pathways. The case numbers of involved endometriosis and control patients were limited. This study only used endometrial stromal cells from patients with or without endometriosis. Ideally, ectopic endometrial stromal cells of the ovarian endometriotic lesions should also be utilized to explore the function of T-cadherin. WIDER IMPLICATIONS OF THE FINDINGS: Further investigation of the role of T-cadherin in endometriosis may generate new potential therapeutic targets for this complex disorder. STUDY FUNDING AND COMPETING INTEREST(S): This study was supported by the Natural Science Foundation of Guangdong Province (2016A030313495), National Natural Science Foundation of China (81702567, 81671406, 31871412), the Science and Technology Programs of Guangdong (2017A050501021), Medical Science Technology Research Fund of Guangdong Province (A2018075), the Science and Technology Programs of Guangzhou City (201704030103), Internal Project of Family Planning Research Institute of Guangdong Province (S2018004), Post-doc initiation fund of Guangzhou (3302) and Post-doc science research initiation fund of Guangzhou Women and Children's Medical Center (20160322). There are no conflicts of interest.
引用
- Lu Q, Huang Y, Wu J, et al. T-cadherin inhibits invasion and migration of endometrial stromal cells in endometriosis. Hum Reprod. 2020. PMID: 31886853. doi:10.1093/humrep/dez252
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。